"Dietary supplements containing
omega-3 fatty acids are not regulated by the FDA.
Omega-3 fatty acids also are known to be important in brain development and function, and have been linked to depression.
Omega-3 fatty acids have been shown to reduce inflammation and oxidative stress on cells and both of those processes damage nerve tissue and have been linked with ALS.
However, these preparations provide pharmacological amounts of
omega-3 fatty acid EEs and are used under strict supervision by a physician.
Other nutrients besides
omega-3 fatty acids were not associated with different blood levels of beta-amyloid.
Low levels of all
omega-3 fatty acids were also associated with poor test scores for visual memory, problem-solving, multi-tasking and abstract thinking.
These data indicate that IgAN patients responded differently to
omega-3 fatty acid supplementation than did healthy controls.
Nevertheless, the Canadian Government has recognized the importance of DHA omega-3 and permits the following biological role claim for DHA: "DHA, an
omega-3 fatty acid, supports the normal development of the brain, eyes and nerves." As awareness has increased regarding the importance of
omega-3 fatty acids to brain health, so the number of products available in the market has increased and the number of food products enriched with
omega-3 fatty acids claiming brain health benefits has also increased.
Leading experts recommend DHA as a key
omega-3 fatty acid for prenatal development.
29 June 2009 - A new value added marketing trend is increasing the
omega-3 fatty acid content in food products aimed to improve cardiovascular health.
TORONTO -- Patients with cardiovascular disease on an oral regimen of
omega-3 fatty acid had a 73% reduced risk for developing atrial fibrillation in a retrospective, observational study of more than 11,000 patients.
In a multivariate model that included all of the known differences between the two groups at baseline,
omega-3 fatty acid use was linked with a statistically significant, 73% reduction in the rate of new atrial fibrillation, the researchers said at the congress, which was sponsored by the International Academy of Cardiology.